Restricted accessResearch articleFirst published online 2017-6
Serial Casting as an Adjunct to Botulinum Toxin Type A Treatment in Children With Cerebral Palsy and Spastic Paraparesis With Scissoring of the Lower Extremities
The purpose of this study was to examine whether combination therapy of serial casting and botulinum toxin type A injection can further enhance the effects of botulinum toxin type A in children with cerebral palsy with scissoring of both legs. This study was a prospective and randomized trial. The children were divided into 2 groups, one of which received serial casting after botulinum toxin type A (n = 40), and the other which only received botulinum toxin type A (n = 40). Serial casting started 3 weeks after the botulinum toxin type A. Both groups received physiotherapy. Groups were assessed at baseline then compared at 6 and 12 weeks following the intervention. Significant improvements in Gross Motor Function Measure–66 and Caregiver Health Questionnaire were recorded in both groups (P < .001). The modified Ashworth scale improved significantly following botulinum toxin type A in the serial casting group (P < .05), but not in botulinum toxin type A only group. These results suggest that serial casting after botulinum toxin type A can enhance the benefits of botulinum toxin type A in children with cerebral palsy.
OskouiMCoutinhoFDykemanJJettéNPringsheimT. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol. 2013;55:509–519.
2.
SerdaroğluACansuAOzkanSTezcanS. Prevalence of cerebral palsy in Turkish children between the ages of 2 and 16 years. Dev Med Child Neurol. 2006;48:413–416.
3.
PalisanoRJRosenbaumPBartlettDLivingstonMH. Content validity of the expanded and revised Gross Motor Function Classification System. Dev Med Child Neurol. 2008;50:744–750.
4.
TiltonA. Management of spasticity in children with cerebral palsy. Semin Pediatr Neurol. 2009;16:82–89.
5.
HuangWFosterJARogachefskyAS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000;43:249–259.
6.
GraciesJM. Physiological effects of botulinum toxin in spasticity. Mov Disord. 2004;19(suppl 8):S120–S128.
7.
MaJShenJLeeCA. Gene expression of nAChR, SNAP-25 and GAP-43 in skeletal muscles following botulinum toxin A injection: a study in rats. J Orthop Res. 2005;23:302–309.
8.
DesloovereKMolenaersGJonkersI. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures. Eur J Neurol. 2001;8(suppl 5):75–87.
9.
O’DwyerNJNeilsonPDNashJ. Mechanisms of muscle growth related to muscle contracture in cerebral palsy. Dev Med Child Neurol. 1989;31:543–547.
10.
CorryISCosgroveAPDuffyCMMcNeillSTaylorTCGrahamHK. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial. J Pediatr Orthop. 1998;18:304–311.
11.
BrouwerBWheeldonRKStradiotto-ParkerNAllumJ. Reflex excitability and isometric force production in cerebral palsy: the effect of serial casting. Dev Med Child Neurol. 1998;40:168–175.
12.
GlanzmanAMKimHSwaminathanKBeckT. Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: a retrospective analysis. Dev Med Child Neurol. 2004;46:807–811.
13.
KayRMRethlefsenSAFern-BuneoAWrenTASkaggsDL. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. J Bone Joint Surg Am. 2004;86-A:2377–2384.
14.
DaiAI. Effectiveness of botulinum toxin type A in cerebral palsy: Low dose or high dose?Neurol Psychiatry Brain Res. 2006;13:147–150.
15.
DaiAIAksoySNDemiryürekAT. Comparison of efficacy and side effects of oral baclofen versus tizanidine therapy with adjuvant botulinum toxin type A in children with cerebral palsy and spastic equinus foot deformity. J Child Neurol. 2016;31:184–189.
ScholtesVADallmeijerAJKnolDL. The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial. Arch Phys Med Rehabil. 2006;87:1551–1558.
18.
BohannonRWSmithMB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67:206–207.
19.
SchneiderJWGurucharriLMGutierrezALGaebler-SpiraDJ. Health-related quality of life and functional outcome measures for children with cerebral palsy. Dev Med Child Neurol. 2001;43:601–608.
20.
BoothMYYatesCCEdgarTSBandyWD. Serial casting vs combined intervention with botulinum toxin A and serial casting in the treatment of spastic equinus in children. Pediatr Phys Ther. 2003;15:216–220.
21.
BottosMBenedettiMGSalucciPGasparroniVGianniniS. Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment. Dev Med Child Neurol. 2003;45:758–762.
22.
NewmanCJKennedyAWalshMO’BrienTLynchBHenseyO. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus. J Pediatr Orthop. 2007;27:882–885.
23.
ParkESRhaDWYooJKKimSMChangWHSongSH. Short-term effects of combined serial casting and botulinum toxin injection for spastic equinus in ambulatory children with cerebral palsy. Yonsei Med J. 2010;51:579–584.
24.
LeeSJSungIYJangDHYiJHLeeJHRyuJS. The effect and complication of botulinum toxin type A injection with serial casting for the treatment of spastic equinus foot. Ann Rehabil Med. 2011;35:344–353.
25.
AckmanJDRussmanBSThomasSS. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol. 2005;47:620–627.
26.
ThompsonSB. An anti-scissoring device for patients with cerebral palsy. J Bone Joint Surg Am. 1957;39-A:218–219.
27.
JainSMathurNJoshiMJindalRGoenkaS. Effect of serial casting in spastic cerebral palsy. Indian J Pediatr. 2008;75:997–1002.
28.
EamesNWBakerRHillNGrahamKTaylorTCosgroveA. The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response. Dev Med Child Neurol. 1999;41:226–232.
29.
LoveSCNovakIKentishM. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement. Eur J Neurol. 2010;17(suppl 2):9–37.
30.
KirshblumS. Treatment alternatives for spinal cord injury related spasticity. J Spinal Cord Med. 1999;22:199–217.
31.
DursunNGokbelTAkarsuMDursunE. A randomized controlled trial on effectiveness of intermittent serial casting on spastic equinus foot in children with cerebral palsy after botulinum toxin-A treatment. Am J Phys Med Rehabil. 2017;96:221–225.
32.
HayekSGershonAWientroubSYizharZ. The effect of injections of botulinum toxin type A combined with casting on the equinus gait of children with cerebral palsy. J Bone Joint Surg Br. 2010;92:1152–1159.
